1News 1News: your global news briefing, coming soon on iOS & Android
Coming Soon
Back to Business
Zevra Therapeutics: Miplyffa Validates The Bull Case, Europe Still The Swing Factor
Business October 6, 2026 at 9:27 AM

Zevra Therapeutics: Miplyffa Validates The Bull Case, Europe Still The Swing Factor

Seeking Alpha
Read the full story at Seeking Alpha
More Stories
Australia PMI Points To Mix Of Elevated Inflation And Softer Growth, Hinting At Cautious Rate Setting
Business
Australia PMI Points To Mix Of Elevated Inflation And Softer Growth, Hinting At Cautious Rate Settin…
🇺🇸 Seeking Alpha 35m ago
Alimentation Couche-Tard: Normalization Has Arrived, Organic Growth Is Sluggish
Business
Alimentation Couche-Tard: Normalization Has Arrived, Organic Growth Is Sluggish
🇺🇸 Seeking Alpha 35m ago
JEPI Is Selling The Wrong Volatility
Business
JEPI Is Selling The Wrong Volatility
🇺🇸 Seeking Alpha 36m ago
1News
Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play